peptide H3

N/A

Report date: 2025/03/20 14:37:44

Base Information

Drug Namepeptide H3
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptideNatural product/Extract
Mechanisms of ActionPI3-kinase class I inhibitorsSerine/threonine-protein kinase mTOR inhibitorsProto-oncogene proteins c-akt inhibitors
TargetsPI3-kinase class IProto-oncogene proteins c-aktSerine/threonine-protein kinase mTOR
Therapy Area/IndicationsLiver Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJinan University
China Registration ClassN/A

Develop Information

Active CompaniesJinan University
Inactive CompaniesN/A
Active IndicationsLiver Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A